BMC showed elevated tumor markers with higher AFP (15,125.0 vs. 48.4 ng/mL, p = 0.03) and PIVKA-II levels (3,556.6 vs. 69.4 mAU/mL, p < 0.01). The gene discussed is AFP; the disease is neoplasm.